Tidal Investments’s Lunai Bioworks LNAI Stock Holding History

Tidal Investments’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-409	Closed	-$57.2K	–	1944
2024 Q2	$57.2K	Sell	409 -53	-11%	-$7.22K	﹤0.01%	1764
2024 Q1	$98K	Buy	+462	New	+$125K	﹤0.01%	1616

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tidal Investments's LNAI Position: Q3 2024 in Review

Tidal Investments sold out of Lunai Bioworks (LNAI) in Q3 2024, closing a stake of 409 shares — an estimated $57.2K sold.

Tidal Investments first reported a position in LNAI in Q1 2024 and held it in 2 quarters. The position peaked at $98K in Q1 2024. 49 funds tracked by Wall St. Rank hold LNAI as of Q3 2024.

Tidal Investments reported no remaining Lunai Bioworks position as of Q3 2024 after selling out during the quarter.
Tidal Investments sold 409 Lunai Bioworks shares in Q3 2024, an estimated $57.2K.
Tidal Investments first reported a position in Lunai Bioworks in Q1 2024 and held it in 2 quarters.
Tidal Investments's Lunai Bioworks position peaked at $98K in Q1 2024.
49 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2024.

Based on Tidal Investments's 13F filing for Q3 2024, filed 14 Nov 2024.